Age-related response to 12-month romosozumab in treatment-naïve Japanese women aged 55–100 years with primary osteoporosis
Bone · 2026
DOI: 10.1016/j.bone.2025.117708 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bone, 2026. Verfasst von Takaomi Kobayashi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Education and Research Center for Community Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan; Department of Ort…. Hauptthemen laut MEDLINE: Osteoporosis, Antibodies, Monoclonal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Japan Orthopaedics and Traumatology Foundation Inc.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Education and Research Center for Community Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan; Department of Orthopaedic Surgery, Faculty of Medicine, Saga University, 5-1-1 Nabeshim…
- Kobayakawa Orthopedic and Rheumatologic Clinic, 1969 Kunou, Fukuroi, Shizuoka, 437-0061, Japan.
- Osteoporosis Locomotive Syndrome & Joint disease Center, Aichi Medical University, 1-1 Yazakokarimata, Nagakute, 480-1195, Japan; Department of Orthopaedic Surgery, Aichi Medical University, 1-1 Yazakokarimata, Nagakute…
Förderung
- Japan Orthopaedics and Traumatology Foundation Inc
Zitieren
APA
Kobayashi, T., Kobayakawa, T., & Nakamura, Y. (2026). Age-related response to 12-month romosozumab in treatment-naïve Japanese women aged 55–100 years with primary osteoporosis. Bone. https://doi.org/10.1016/j.bone.2025.117708
Vancouver
Kobayashi T, Kobayakawa T, Nakamura Y. Age-related response to 12-month romosozumab in treatment-naïve Japanese women aged 55–100 years with primary osteoporosis. Bone. 2026. doi:10.1016/j.bone.2025.117708
BibTeX
@article{Kobayashi2026,
author = {Kobayashi, Takaomi and Kobayakawa, Tomonori and Nakamura, Yukio},
title = {Age-related response to 12-month romosozumab in treatment-naïve Japanese women aged 55–100 years with primary osteoporosis},
journal = {Bone},
year = {2026},
doi = {10.1016/j.bone.2025.117708}
}
EUVIMED